BETA Technologies reported Q1 2026 results on May 12 that beat on both lines, yet the stock closed the day 2.6% lower — and the most striking backdrop to that session was a coordinated cluster of executive sales that hit the tape at the same price.
The earnings print itself was constructive. Q1 EPS came in at -$0.53, an 13 cents above the -$0.61 consensus, while revenue of $10.1M beat the $8.6M estimate by roughly 18%. Full-year 2026 sales guidance was affirmed at $39M–$43M, bracketing the $40.1M Street estimate. On the face of it, that is a clean beat-and-maintain. The stock's muted reaction — down on the day despite a 5.4% gain on the week — likely reflects both the sell-the-news dynamic and the insider activity that was impossible to miss.
On May 7, every named C-suite officer filed sales at $18.12. CEO Kyle Clark sold just under 72,000 shares combined, raising over $1.3M. The COO, CFO, CTO, and Chief Legal Officer each sold positions in the $170K–$345K range. The Chief Accounting Officer trimmed a symbolic 370 shares. None of these are individually alarming at a recently-listed growth name where compensation is share-heavy, but the synchronised nature of the cluster — same date, same price, across every executive — is the kind of pattern that draws scrutiny. Net 90-day insider activity across the register is positive at roughly 139,000 shares, suggesting prior awards and vesting more than offset the sales in aggregate, but the directional read at the individual C-suite level is clearly outward.
Short positioning has moved in the opposite direction, and the divergence is meaningful. Short interest fell roughly 14% on the week and 18% over the past month, landing at 2.5% of free float — a level that is modest in absolute terms. The cost to borrow has eased from mid-April highs near 3.6% down to 0.68%, among the lowest readings in the trailing six weeks. Borrow availability, while not at the loosest end of the range, is nowhere near squeeze territory given the moderate SI level. The ORTEX short score has drifted from ~60 at the start of May to 55.5, reinforcing the picture of bears stepping back rather than pressing. Options tell the same story from a different angle: the put/call ratio collapsed from above 1.68 — near its 52-week peak — just two weeks ago to 0.83 today, almost two standard deviations below its 20-day average of 1.42. Call positioning is now clearly dominant, the most bullish options skew of the past year.
The Street has mostly held ratings firm while trimming price targets. Both Cantor Fitzgerald and Needham commented on May 13 — the day after earnings — with Cantor lowering its target from $38 to $31 while keeping Overweight, and Needham reiterating Buy at $34. Goldman Sachs trimmed from $38 to $34 in late April, also maintaining Buy. Across the recent changes, the direction of travel is lower targets but unchanged bullish ratings — a tell that analysts believe the thesis is intact but are adjusting for a stock that has re-rated. The mean target around $34–$35 implies roughly 90% upside to the current $18.11 price, though that gap reflects the unprofitable-growth-stage profile rather than a conventional valuation mismatch. Price-to-book of 3.1x has risen about 10% over the past month as the stock climbed; PE and EV/EBITDA multiples are negative given current losses, and there is no dividend. The bull case centres on BETA's position in the nascent electric aviation market and its named customer relationships — Amazon and GE are two of the top three institutional holders. The bear case is straightforward: no certified aircraft, no scaled production, and limited financial history on which to anchor a view.
Institutional ownership is concentrated and strategically interesting. FMR (Fidelity) leads at 14.4%, GE holds 8.8% (a strategic stake that shrank by 2.6M shares in Q1), and Amazon sits at 5.1% unchanged. The co-founders and early executives — CEO Clark, CFO colleague Austin Meyer, and Charles Davis — collectively hold over 20% of shares. TPG, Vanguard, BlackRock, and T. Rowe Price all initiated or added positions in the most recent reporting period, suggesting institutional accumulation is still in an early phase. TPG's 7.1% stake was entirely new as of year-end 2025.
The Q1 report from March 2026 provides the only prior earnings reaction data point: the stock rose 3.7% on the day but gave back 12.6% over the following five days. The next scheduled event is June 4. With short interest now lighter, options skew firmly bullish, and a fresh beat on the books, the primary question heading into that date is whether the post-Q1 five-day fade repeats — or whether the reduction in short positioning and the shift toward calls signals a different kind of holder base going into the next print.
See the live data behind this article on ORTEX.
Open BETA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
